Gold
nanoparticles (AuNPs) bound with biomolecules have emerged
as suitable biosensors exploiting unique surface chemistries and optical
properties. Many efforts have focused on antibody bioconjugation to
AuNPs resulting in a sensitive bioconjugate to detect specific types
of bacteria. Unfortunately, bacteria thrive under various harsh environments,
and an understanding of bioconjugate stability is needed. Here, we
show a method for optimizing Listeria monocytogenes polyclonal antibodies bioconjugation mechanisms to AuNPs via covalent
binding at different pH values, from 2 to 11, and 2-(N-morpholino)ethanesulfonic acid (MES), 3-(N-morpholino)propanesulfonic
acid, NaOH, HCl conditions. By fitting Lorentz curves to the amide
I and II regions, we analyze the stability of the antibody secondary
structure. This shows an increase in the apparent breakdown of the
antibody secondary structure during bioconjugation as pH decreases
from 7.9 to 2. We find variable adsorption efficiency, measured as
the percentage of antibody adsorbed to the AuNP surface, from 17 to
27% as pH increases from 2 to 6 before decreasing to 8 and 13% at
pH 7.9 and 11, respectively. Transmission electron microscopy (TEM)
analysis reveals discrepancies between size and morphological changes
due to the corona layer assembly from antibody binding to single nanoparticles
versus aggregation or cluster self-assembly into large aggregates.
The corona layer formation size increases from 3.9 to 5.1 nm from
pH 2 to 6, at pH 7.9, there is incomplete corona formation, whereas
at pH 11, there is a corona layer formed of 6.4 nm. These results
indicate that the covalent binding process was more efficient at lower
pH values; however, aggregation and deactivation of the antibodies
were observed. We demonstrate that optimum bioconjugation condition
was determined at pH 6 and MES buffer-type by indicators of covalent
bonding and stability of the antibody secondary structure using Fourier
transform-infrared, the morphological characteristics and corona layer
formation using TEM, and low wavelength shifts of ultraviolet–visible
after bioconjugation.
Single-molecule detection has become an indispensable technology in life science, and medical research. In order to get meaningful information on many biological processes, single-molecule analysis is required in micro-molar concentrations. At such high concentrations, it is very challenging to isolate a single molecule with conventional diffraction-limited optics. Recently, optical aperture nanoantennas (OANs) have emerged as a powerful tool to enhance the single-molecule detection under a physiological environment. The OANs, which consist of nano-scale apertures on a metallic film, have the following unique properties: (1) nanoscale light confinement; (2) enhanced fluorescence emission; (3) tunable radiation pattern; (4) reduced background noise; and (5) massive parallel detection. This review presents the fundamentals, recent developments and future perspectives in this emerging field.
A rapid and cost-effective method for the fabrication of nanogap-rich structures is demonstrated in this Letter. The method utilizes the Marangoni convection around an optothermal surface bubble inside a liquid droplet with a nanoliter volume. The liquid droplet containing metallic nanoparticles reduces the sample consumption and confines the liquid flow. The optothermal surface bubble creates a strong convective flow that allows for the rapid deposition of the metallic nanoparticles to form nanogap-rich structures on any substrate under ambient conditions. This method will enable a broad range of applications such as biosensing, environmental analysis, and nonlinear optics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.